FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula (I): 
. Therein the values A, R1, R2, R6, r, Rc are presented in cl.1 of the patent claim, as well as to pharmaceutically acceptable salts or tautomers of the above compound being poly(ADP-ribose)polymerase (PARP) inhibitors.
EFFECT: preparing the pharmaceutically acceptable salts or tautomers of the above compound being poly(ADP-ribose)polymerase (PARP) inhibitors.
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
| TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
| INHIBITORS OF NONPRILYZINE | 2011 |
|
RU2622288C2 |
| HETEROCYCLIC IMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF | 2016 |
|
RU2686314C1 |
| SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | 2012 |
|
RU2604522C2 |
| HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
| SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
| MAGL INHIBITORS | 2017 |
|
RU2754536C1 |
| AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LYPASE INHIBITORS | 2010 |
|
RU2549547C2 |
| QUINOXALINES AND AZAQUINOXALINES AS CRTH RECEPTOR MODULATORS | 2011 |
|
RU2589709C2 |
